CODX
Co-diagnostics·NASDAQ
--
--(--)
--
--(--)
CODX fundamentals
Co-diagnostics (CODX) expects to report earnings on Mar 31, 2026, with estimated revenue of 125.88K (YoY -15.70%), and EPS at -3.6 (YoY +66.67%).
Revenue estimate / YoY
125.88K
-15.70%
EPS estimate / YoY
-3.6
+66.67%
Report date
Mar 31, 2026
CODX Earnings Call Summary for Q4,2025
- Strategic Momentum: Advanced India expansion (CoSara SPAC exploration, $13B South Asia market), Saudi Arabia manufacturing, and TB clinical trials aligned with WHO guidelines.
- Clinical Pipeline Progress: Upper respiratory test nearing FDA submission; TB program targeting Q3 2026 India launch. Removed COVID-19 target but保留flexibility to reintroduce.
- Financial Challenges: 2025 net loss $46.9M due to $18.9M impairment charge; cash down 60% to $11.9M. Focus on disciplined spending and ATM capital access.
- AI & IP Strength: Expanded AI capabilities for predictive diagnostics; secured key patents in Japan and Australia.
- Commercialization Timeline: Target TB test launch in India Q3 2026; U.S. FDA submission for flu/RSV test pending analytical studies.
Earnings
EPS
Revenue
Revenue & Expenses
CODX has released its 2025 Q4 earnings report, with revenue of 263.92K, reflecting a YoY change of 76.74%, and net profit of -25.75M, showing a YoY change of -133.39%. The Sankey diagram below clearly presents CODX's revenue sources and cost distribution.
Key Indicators
Co-diagnostics (CODX) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Co-diagnostics (CODX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Co-diagnostics (CODX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Co-diagnostics (CODX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Co-diagnostics (CODX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Co-diagnostics (CODX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Co-diagnostics's latest dividend and current dividend yield?What were the key takeaways from Co-diagnostics's earnings call?What is the revenue and EPS growth rate for Co-diagnostics year over year?Did Co-diagnostics beat or miss consensus estimates last quarter?What were the key takeaways from Co-diagnostics’s earnings call?What is Co-diagnostics's gross profit margin?What guidance did Co-diagnostics's management provide for the next earnings period?What does Co-diagnostics do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
